BPCA Adverse Event Reports To Be Presented According To Three-Tier System
Executive Summary
FDA has developed a three-tier system for its presentations of pediatric drug adverse event reports to its Pediatric Advisory Committee, as mandated by the Best Pharmaceuticals for Children Act